Grage Katrin, Rehm Bernd H A
Institute of Molecular Biosciences, Massey University, Private Bag 11222, Palmerston North 4442, New Zealand.
Bioconjug Chem. 2008 Jan;19(1):254-62. doi: 10.1021/bc7003473. Epub 2007 Dec 19.
Recombinant production and, in particular, immobilization of antibody fragments onto carrier materials are of high interest with regard to diagnostic and therapeutic applications. In this study, the recombinant production of scFv-displaying biopolymer beads intracellularly in Escherichia coli was investigated. An anti-beta-galactosidase scFv (single chain variable fragment of an antibody) was C-terminally tagged with the polymer-synthesizing enzyme PhaC from Cupriavidus necator by generating the respective hybrid gene. The functionality of the anti-beta-galactosidase scFv-PhaC fusion protein was assessed by producing the respective soluble fusion protein in an Escherichia coli AMEF mutant strain. AMEF (antibody-mediated enzyme formation) strains contain an inactive mutant beta-galactosidase, which can be activated by binding of an anti-beta-galactosidase antibody. In vivo activation of AMEF beta-galactosidase indicated that the scFv is functional with the C-terminal fusion partner PhaC. It was further demonstrated that polymer biosynthesis and bead formation were mediated by the scFv-PhaC fusion protein in the cytoplasm of recombinant E. coli when the polymer precursor was metabolically provided. This suggested that the C-terminal fusion partner PhaC acts as a functional insolubility partner, providing a natural cross-link to the bead and leading to in vivo immobilization of the scFv. Overproduction of the fusion protein at the polymer bead surface was confirmed by SDS-PAGE and MALDI-TOF/MS analysis of purified beads. Antigen binding functionality and specificity of the beads was assessed by analyzing the binding of beta-galactosidase to scFv-displaying beads and subsequently eluting the bound protein at pH 2.7. A strong enrichment of beta-galactosidase suggested the functional display of scFv at the bead surface as well as the applicability of these beads for antigen purification. Binding of beta-galactosidase to the scFv-displaying beads was quantitatively analyzed by enzyme-linked assays measuring beta-galactosidase activity. These indicated that the anti-beta-galactosidase scFv-displaying beads bound a maximum of 38 ng of beta-galactosidase per 1 microg of bead protein, showing an apparent equilibrium dissociation constant ( KD) of 12 x 10 (-7) M. This study clearly demonstrated that anti-beta-galactosidase scFv-displaying polymer beads can be produced in engineered E. coli in a one-step process by using PhaC as a self-assembly-promoting fusion partner.
重组生产,特别是将抗体片段固定在载体材料上,在诊断和治疗应用方面具有很高的研究价值。在本研究中,对在大肠杆菌细胞内重组生产展示单链抗体片段(scFv)的生物聚合物珠进行了研究。通过构建相应的杂交基因,将抗β-半乳糖苷酶scFv(抗体的单链可变片段)在C末端与来自贪铜菌的聚合物合成酶PhaC进行融合标记。通过在大肠杆菌AMEF突变株中生产相应的可溶性融合蛋白,评估了抗β-半乳糖苷酶scFv-PhaC融合蛋白的功能。AMEF(抗体介导的酶形成)菌株含有无活性的突变型β-半乳糖苷酶,其可通过抗β-半乳糖苷酶抗体的结合而被激活。AMEFβ-半乳糖苷酶的体内激活表明scFv与C末端融合伴侣PhaC具有功能性。进一步证明,当代谢提供聚合物前体时,聚合物生物合成和珠形成由重组大肠杆菌细胞质中的scFv-PhaC融合蛋白介导。这表明C末端融合伴侣PhaC作为功能性不溶性伴侣,为珠提供天然交联,导致scFv在体内固定。通过对纯化珠的SDS-PAGE和MALDI-TOF/MS分析,证实了融合蛋白在聚合物珠表面的过量表达。通过分析β-半乳糖苷酶与展示scFv的珠的结合,并随后在pH 2.7下洗脱结合的蛋白,评估了珠的抗原结合功能和特异性。β-半乳糖苷酶的强烈富集表明scFv在珠表面的功能性展示以及这些珠用于抗原纯化的适用性。通过测量β-半乳糖苷酶活性的酶联测定法定量分析了β-半乳糖苷酶与展示scFv的珠的结合。结果表明,每1μg珠蛋白上展示抗β-半乳糖苷酶scFv的珠最多可结合38 ng的β-半乳糖苷酶,表观平衡解离常数(KD)为12×10(-7)M。本研究清楚地表明,通过使用PhaC作为自组装促进融合伴侣,可在工程化大肠杆菌中一步法生产展示抗β-半乳糖苷酶scFv的聚合物珠。